These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6381968)

  • 1. Does calcium potentiate the bone-preserving effect of oestrogen treatment in early post-menopausal women by a change in vitamin D metabolism?
    Riis BJ; Christiansen C
    Maturitas; 1984 Jul; 6(1):65-70. PubMed ID: 6381968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
    Jensen GF; Christiansen C; Transbøl I
    Clin Endocrinol (Oxf); 1982 May; 16(5):515-24. PubMed ID: 7044620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
    Riis BJ; Johansen J; Christiansen C
    Maturitas; 1988 May; 10(1):51-8. PubMed ID: 3041248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photon absorptiometry studies in osteoporosis.
    Christiansen C
    Acta Obstet Gynecol Scand Suppl; 1985; 130():67-70. PubMed ID: 3893022
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of natural oestrogen/gestagen therapy on uric acid metabolism in post-menopausal women.
    Gotfredsen A; Christiansen C; Transbøl I
    Maturitas; 1983 Jun; 5(1):9-15. PubMed ID: 6348486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
    Christiansen C; Riis BJ
    Br J Obstet Gynaecol; 1990 Dec; 97(12):1087-92. PubMed ID: 2126198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect on lipoproteins of Trisequens, a combined hormone preparation.
    Fletcher CD; Farish E; Hart DM; Leggate J; Clark DM; Kitchener H; Sharpe GL
    Maturitas; 1984 Nov; 6(3):279-83. PubMed ID: 6595494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis.
    Christiansen C; Riis BJ; Nilas L; Rødbro P; Deftos L
    Lancet; 1985 Oct; 2(8459):800-1. PubMed ID: 2864532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.
    Pødenphant J; Christiansen C; Catherwood BD; Deftos LJ
    Calcif Tissue Int; 1984 Sep; 36(5):536-40. PubMed ID: 6441624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women.
    Jensen J; Christiansen C
    Maturitas; 1987 Nov; 9(3):259-66. PubMed ID: 3323852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
    Jensen J; Christiansen C; Rødbro P
    N Engl J Med; 1985 Oct; 313(16):973-5. PubMed ID: 4047104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.
    Steiniche T; Hasling C; Charles P; Eriksen EF; Mosekilde L; Melsen F
    Bone; 1989; 10(5):313-20. PubMed ID: 2690898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.
    Jensen J; Nilas L; Christiansen C
    Br J Obstet Gynaecol; 1986 Jun; 93(6):613-8. PubMed ID: 3730329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
    Christiansen C; Christensen MS; Rødbro P; Hagen C; Transbøl I
    Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
    Christiansen C; Rødbro P; Tjellesen L
    Acta Med Scand; 1984; 216(1):11-7. PubMed ID: 6385631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment.
    Christiansen C; Christensen MS; Grande P; Transbøl I
    Maturitas; 1984 Mar; 5(3):193-9. PubMed ID: 6727693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trisequens.
    Drug Ther Bull; 1981 Jul; 19(16):63-4. PubMed ID: 7274066
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
    Jensen J; Riis BJ; Strøm V; Christiansen C
    Maturitas; 1989 Jun; 11(2):117-28. PubMed ID: 2547137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
    Christiansen C; Riis BJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):836-41. PubMed ID: 2205624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does oestriol add to the beneficial effect of combined hormonal prophylaxis against early postmenopausal osteoporosis?
    Christiansen C; Rødbro P
    Br J Obstet Gynaecol; 1984 May; 91(5):489-93. PubMed ID: 6722065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.